The results indicated that BefA could recover the number of islet β cells and islet function of T1DM mice via reducing the Bax/Bcl-2 ratio, increasing the expression of PDX-1 and promoting insulin secretion (Figure 3). Here, BAX is linked to type 1 diabetes mellitus.